Reduced high-molecular weight adiponectin and elevated hsCRP are synergistic risk factors for metabolic syndrome in a large scale middle-aged to elderly population: the J-SHIPP study

High-sensitivity C-reactive protein predicts target organ damage in Chinese patients with metabolic syndrome

Leptin and high-sensitivity C-reactive protein and their interaction in the metabolic syndrome in middle-aged subjects

C-reactive protein, an 'intermediate phenotype' for inflammation: human twin studies reveal heritability, association with blood pressure and the metabolic syndrome, and the influence of common polymorphism at catecholaminergic/[beta]-adrenergic pathway loci.

Serum C-reactive protein levels correlates better to metabolic syndrome defined by International Diabetes Federation than by NCEP ATP III in men

Dietary intakes of fat and antioxidant vitamins are predictors of subclinical inflammation in overweight Swiss children1,2,3

Relation of Improvement in Endothelium-Dependent Flow-Mediated Vasodilation After Rosiglitazone to Changes in Asymmetric Dimethylarginine, Endothelin-1, and C-Reactive Protein in Nondiabetic Patients With the Metabolic Syndrome

Impact of metabolic syndrome on CRP levels

Obesity is a major determinant of the association of C-reactive protein levels and the metabolic syndrome in type 2 diabetes.

Metabolic syndrome, C-reactive protein, and prognosis in patients with established coronary artery disease.

Inflammation and Changes in Metabolic Syndrome Abnormalities in US Adolescents: Findings from the 1988–1994 and 1999–2000 National Health and Nutrition Examination Surveys

Metabolic syndrome, insulin resistance and the inflammation markers C-reactive protein and ferritin

Distribution and metabolic syndrome correlates of plasma C-reactive protein in biracial (black-white) younger adults: the Bogalusa Heart Study

Effect of Rosiglitazone on Endothelial Function and Inflammatory Markers in Patients With the Metabolic Syndrome

Effects of Etanercept in Patients With the Metabolic Syndrome

C-Reactive Protein and Metabolic Syndrome in Elderly Women: A 12-year follow-up study

Association of C-reactive protein with the metabolic risk factors among young and middle-aged Koreans

Effects of Rosiglitazone on Lipids, Adipokines, and Inflammatory Markers in Nondiabetic Patients With Low High-Density Lipoprotein Cholesterol and Metabolic Syndrome

The Metabolic Syndrome: Inflammation, Diabetes Mellitus, and Cardiovascular Disease

C-reactive protein is elevated in obese patients with the metabolic syndrome

Inflammatory Markers and the Metabolic Syndrome: Insights From Therapeutic Interventions

Central obesity as a major determinant of increased high-sensitivity C-reactive protein in metabolic syndrome

Liver Markers and Development of the Metabolic Syndrome: The Insulin Resistance Atherosclerosis Study

Distribution and metabolic syndrome correlates of plasma C-reactive protein in biracial (Black-White) younger adults: The Bogalusa Heart Study

C-reactive protein level as an independent risk factor of metabolic syndrome in the Korean population: CRP as risk factor of metabolic syndrome